Investor alerts, case updates, and legal insights from the attorneys at Bronstein, Gewirtz & Grossman, LLC.
On October 21, 2026, Community Trust reported its third-quarter 2026 financial results, including earnings per share of $1.43, revenue of $79.7 million, and net loan charge-offs of $6.6 million. The Company disclosed that the increase in net loan charge-offs was primarily attributable to an $8.7…
On October 19, 2026, Dynex reported its third-quarter 2026 financial results, disclosing a book value per common share of $10.91 as of September 30, 2026, a decrease of $1.99 per share, or 15.4%, from the prior quarter. The Company attributed the decline to late-quarter volatility and widening…
On October 19, 2026, Home Bancorp reported its third-quarter 2026 financial results, disclosing net income of $10.1 million, or $1.28 per diluted share, down from $11.6 million, or $1.48 per diluted share, in the prior quarter. The Company also disclosed that nonperforming loans increased from…
On October 19, 2026, FreightCar announced preliminary third-quarter 2026 financial results and disclosed that it was removing 1,285 railcars associated with a tank car retrofit order from its backlog after determining that the customer was unlikely to fulfill its contractual obligations. Following…
On October 15, 2026, FMC issued a press release “updat[ing] its expectations for third quarter 2026.” FMC advised that “[r]evenue is now expected to be between $65 million and $125 million with expected Adjusted EBITDA of negative $565 million to negative $510 million.” The Company said that…
On October 12, 2026, Syndax Pharmaceuticals announced that its Phase 2 MAXPIRe clinical trial evaluating axatilimab failed to meet its primary endpoint. Following this news, Syndax's stock price declined more than 15.7% on October 13, 2026.
The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: 1. Systemic weaknesses in Bank of America's Bank Secrecy Act and Anti-Money Laundering (“BSA/AML”) compliance program caused BAC to fail to properly monitor…
Be the first to know when BG&G files a new class action or announces a settlement deadline. No spam — only case-relevant alerts.
By subscribing you agree to our Privacy Policy. Unsubscribe anytime.